Prescription drug · ANDA
Bupropion Hydrochloride NDC 71209-053
Bupropion hydrochloride 100 mg/1 · Tablet, Film coated · Oral · Cadila Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71209-053-05 | 71209005305 | 100 TABLET, FILM COATED in 1 BOTTLE (71209-053-05)Marketed from Jan 12, 2023 | |
| 71209-053-11 | 71209005311 | 1000 TABLET, FILM COATED in 1 BOTTLE (71209-053-11)Marketed from Jan 12, 2023 | |
| 71209-053-17 | 71209005317 | 10 BLISTER PACK in 1 CARTON (71209-053-17) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jan 12, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bupropion Hydrochloride
- Generic name (nonproprietary)
- bupropion hydrochloride
- Active ingredients
- Bupropion hydrochloride — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208606
- Marketing start
- Listing expires
- Other FDA classes
- Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 71209-053_fff2e22d-64c2-425f-823f-a34664d4b1aaSPL ID fff2e22d-64c2-425f-823f-a34664d4b1aaSPL set ID 33210109-2ddb-4b0f-a45e-988e493ca628RxCUI 993687, 993691UNII ZG7E5POY8OUPC 0371209053112, 0371209052115
- Pharmacologic class
- Aminoketone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471209005305followed by a unit qualifier and the quantityPackage 71209-0053-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies (14) ] . Bupropion hydrochloride tablets are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). (1)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 208606
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bupropion Hydrochloride | Bupropion hydrochloride 75 mg/1 | Tablet, Film coatedOral | Modavar Pharmaceuticals LLC | 72241-020 |
| Bupropion Hydrochloride | Bupropion hydrochloride 100 mg/1 | Tablet, Film coatedOral | Modavar Pharmaceuticals LLC | 72241-021 |
| Bupropion Hydrochloride | Bupropion hydrochloride 75 mg/1 | Tablet, Film coatedOral | Cadila Pharmaceuticals Limited | 71209-052 |